Daniel I. Feig

15.5k total citations · 6 hit papers
86 papers, 11.1k citations indexed

About

Daniel I. Feig is a scholar working on Nephrology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Daniel I. Feig has authored 86 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Nephrology, 30 papers in Pathology and Forensic Medicine and 24 papers in Epidemiology. Recurrent topics in Daniel I. Feig's work include Gout, Hyperuricemia, Uric Acid (37 papers), Alcohol Consumption and Health Effects (29 papers) and Liver Disease Diagnosis and Treatment (20 papers). Daniel I. Feig is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (37 papers), Alcohol Consumption and Health Effects (29 papers) and Liver Disease Diagnosis and Treatment (20 papers). Daniel I. Feig collaborates with scholars based in United States, Mexico and South Korea. Daniel I. Feig's co-authors include Richard J. Johnson, Duk‐Hee Kang, Beth Soletsky, Takahiko Nakagawa, Jaime Herrera-Acosta, Laura Gabriela Sánchez‐Lozada, Katherine R. Tuttle, Bernardo Rodríguez‐Iturbe, Marilda Mazzali and Thomas M. Reid and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Daniel I. Feig

85 papers receiving 10.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Uric Acid and Cardiovascular Risk

2008 1.8k citations Daniel I. Feig, Duk‐Hee Kang et al. profile →
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?

2003 1.1k citations Richard J. Johnson, Duk‐Hee Kang et al. profile →
A causal role for uric acid in fructose-induced metabolic syndrome

2005 854 citations Takahiko Nakagawa, Xiaosen Ouyang et al. profile →
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease

2007 808 citations Richard J. Johnson, Mark S. Segal et al. profile →
Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension

2008 665 citations Daniel I. Feig, Beth Soletsky et al. JAMA profile →
Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association

2016 414 citations Daniel I. Feig et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel I. Feig United States	46	6.1k	3.0k	2.5k	2.4k	2.3k	86	11.1k
Bernardo Rodríguez‐Iturbe Venezuela	65	5.8k 1.0×	2.3k 0.8×	2.1k 0.8×	2.7k 1.1×	2.7k 1.2×	233	14.0k
Michel Chonchol United States	62	5.8k 1.0×	3.0k 1.0×	2.5k 1.0×	1.8k 0.7×	2.0k 0.9×	320	14.2k
Mehmet Kanbay Türkiye	58	5.7k 0.9×	1.5k 0.5×	1.9k 0.8×	2.0k 0.8×	1.8k 0.8×	433	12.6k
Akira Hishida Japan	48	4.7k 0.8×	1.3k 0.4×	1.5k 0.6×	2.2k 0.9×	1.5k 0.7×	298	13.6k
Duk‐Hee Kang South Korea	59	12.2k 2.0×	5.2k 1.7×	4.0k 1.6×	5.0k 2.1×	2.9k 1.3×	153	19.0k
Barry I. Freedman United States	65	6.2k 1.0×	853 0.3×	1.7k 0.7×	3.3k 1.3×	3.2k 1.4×	420	16.3k
Shin‐Wook Kang South Korea	55	6.1k 1.0×	904 0.3×	1.3k 0.5×	2.2k 0.9×	1.3k 0.6×	530	12.4k
Ian H. de Boer United States	70	7.6k 1.2×	3.7k 1.2×	1.8k 0.7×	2.4k 1.0×	6.3k 2.7×	325	19.8k
John H. Eckfeldt United States	55	3.9k 0.6×	1.1k 0.3×	1.8k 0.7×	1.7k 0.7×	2.2k 0.9×	194	14.9k
Ziad A. Massy France	69	11.5k 1.9×	1.4k 0.5×	1.4k 0.6×	3.6k 1.5×	1.8k 0.8×	440	21.9k

Countries citing papers authored by Daniel I. Feig

Since Specialization

Citations

This map shows the geographic impact of Daniel I. Feig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel I. Feig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel I. Feig more than expected).

Fields of papers citing papers by Daniel I. Feig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel I. Feig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel I. Feig. The network helps show where Daniel I. Feig may publish in the future.

Co-authorship network of co-authors of Daniel I. Feig

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel I. Feig. A scholar is included among the top collaborators of Daniel I. Feig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel I. Feig. Daniel I. Feig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sánchez‐Lozada, Laura Gabriela, Magdalena Madero, Marilda Mazzali, et al.. (2023). Sugar, salt, immunity and the cause of primary hypertension. Clinical Kidney Journal. 16(8). 1239–1248. 7 indexed citations

Bjornstad, Erica C., Michael E. Seifert, Keia Sanderson, & Daniel I. Feig. (2021). Kidney implications of SARS-CoV2 infection in children. Pediatric Nephrology. 37(7). 1453–1467. 10 indexed citations

Sato, Yuka, Daniel I. Feig, Austin G. Stack, et al.. (2020). Reply to ‘The case for evidence-based medicine for the association between hyperuricaemia and CKD’. Nature Reviews Nephrology. 16(7). 422–423.

Paulsen, Grant, et al.. (2019). Cytomegalovirus and Epstein‐Barr virus infections among pediatric kidney transplant recipients at a center using universal Valganciclovir Prophylaxis. Pediatric Transplantation. 23(3). e13382–e13382. 13 indexed citations

Sato, Yuka, Daniel I. Feig, Austin G. Stack, et al.. (2019). The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD. Nature Reviews Nephrology. 15(12). 767–775. 138 indexed citations

Moudgil, Asha, Vikas R. Dharnidharka, Daniel I. Feig, et al.. (2018). Phase I study of single-dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipients. American Journal of Transplantation. 19(4). 1218–1223. 13 indexed citations

Mrug, Sylvie, et al.. (2017). Uric Acid Excretion Predicts Increased Blood Pressure Among American Adolescents of African Descent. The American Journal of the Medical Sciences. 353(4). 336–341. 9 indexed citations

Feig, Daniel I.. (2012). Hyperuricemia and Hypertension. Advances in Chronic Kidney Disease. 19(6). 377–385. 58 indexed citations

Feig, Daniel I.. (2012). The Role of Uric Acid in the Pathogenesis of Hypertension in the Young. Journal of Clinical Hypertension. 14(6). 346–352. 62 indexed citations

10.

Feig, Daniel I.. (2011). Uric Acid and Hypertension. Seminars in Nephrology. 31(5). 441–446. 43 indexed citations

11.

Kim, Kyung Mee, George N. Henderson, Xiaosen Ouyang, et al.. (2009). A sensitive and specific liquid chromatography–tandem mass spectrometry method for the determination of intracellular and extracellular uric acid. Journal of Chromatography B. 877(22). 2032–2038. 63 indexed citations

12.

Feig, Daniel I., Beth Soletsky, & Richard J. Johnson. (2008). Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension. JAMA. 300(8). 924–924. 665 indexed citations breakdown →

13.

Johnson, Richard J., Daniel I. Feig, Takahiko Nakagawa, Laura Gabriela Sánchez‐Lozada, & Bernardo Rodríguez‐Iturbe. (2008). Pathogenesis of essential hypertension: historical paradigms and modern insights. Journal of Hypertension. 26(3). 381–391. 88 indexed citations

14.

Ludwig, Andrew D., et al.. (2007). Recent advances in the diagnosis and treatment of pheochromocytoma in children. The American Journal of Surgery. 194(6). 792–797. 41 indexed citations

15.

Nakagawa, Takahiko, Duk‐Hee Kang, Daniel I. Feig, et al.. (2006). Unearthing uric acid: An ancient factor with recently found significance in renal and cardiovascular disease. Kidney International. 69(10). 1722–1725. 144 indexed citations

16.

Feig, Daniel I.. (2005). Uric acid and hypertension in adolescents. Seminars in Nephrology. 25(1). 32–38. 17 indexed citations

17.

Askenazi, David J., et al.. (2005). 3–5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney International. 69(1). 184–189. 318 indexed citations

18.

Sánchez‐Lozada, Laura Gabriela, Takahiko Nakagawa, Duk‐Hee Kang, et al.. (2005). Hormonal and cytokine effects of uric acid. Current Opinion in Nephrology & Hypertension. 15(1). 30–33. 53 indexed citations

19.

Feig, Daniel I., Takahiko Nakagawa, S. Ananth Karumanchi, et al.. (2004). Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney International. 66(1). 281–287. 177 indexed citations

20.

Reid, Thomas M., Daniel I. Feig, & L A Loeb. (1994). Mutagenesis by metal-induced oxygen radicals.. Environmental Health Perspectives. 102(suppl 3). 57–61. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact